Cargando…

Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency

OBJECTIVE: We previously reported that patients with cholesteryl ester transfer protein (CETP) deficiency (CETP-D) have a higher prevalence of atherosclerotic cardiovascular disease, in spite of increased HDL-C levels. However, characterization of HDL in CETP-D has not been well described. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okada, Takeshi, Ohama, Tohru, Okazaki, Mitsuyo, Kanno, Kotaro, Matsuda, Hibiki, Sairyo, Masami, Zhu, Yinghong, Saga, Ayami, Kobayashi, Takuya, Masuda, Daisaku, Koseki, Masahiro, Nishida, Makoto, Sakata, Yasushi, Yamashita, Shizuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755928/ https://www.ncbi.nlm.nih.gov/pubmed/29304079 http://dx.doi.org/10.1371/journal.pone.0190875

Ejemplares similares

Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction
por: Liu, Jingyi, et al.
Publicado: (2019)

A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice
por: Sairyo, Masami, et al.
Publicado: (2018)

Erratum:A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice
por: Sairyo, Masami, et al.
Publicado: (2018)

Development and Clinical Application of an Enzyme-Linked Immunosorbent Assay for Oxidized High-Density Lipoprotein
por: Okada, Takeshi, et al.
Publicado: (2021)

Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia
por: Tanaka, Katsunao, et al.
Publicado: (2023)

Evolving neural network optimization of cholesteryl ester separation by reversed-phase HPLC
por: Jansen, Michael A., et al.
Publicado: (2010)

Dietary Oxysterol, 7-Ketocholesterol Accelerates Hepatic Lipid Accumulation and Macrophage Infiltration in Obese Mice
por: Chang, Jiuyang, et al.
Publicado: (2021)

Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy
por: Kanno, Kotaro, et al.
Publicado: (2022)

Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate
por: Yamashita, Shizuya, et al.
Publicado: (2021)

Development of internal standard for lipoprotein subclass analysis using dual detection gel-permeation high-performance liquid chromatography system
por: Ogino, Mei, et al.
Publicado: (2022)

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
por: Chapman, M. John, et al.
Publicado: (2010)

A Dietary Oxysterol, 7-Ketocholesterol, Exacerbates Imiquimod-Induced Psoriasis-like Dermatitis in Steatohepatitic Mice
por: Saga, Ayami, et al.
Publicado: (2022)

Assessing the mechanisms of cholesteryl ester transfer protein inhibitors
por: Zhang, Meng, et al.
Publicado: (2017)

Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial)
por: Masuda, Daisaku, et al.
Publicado: (2018)

Concentration dependent cholesteryl-ester and wax-ester structural relationships and meibomian gland dysfunction
por: Hetman, Zofia A., et al.
Publicado: (2020)

Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins
Publicado: (1979)

Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib
por: Goldberg, Alyse S, et al.
Publicado: (2012)

Cholesteryl Ester Transfer Protein Gene Polymorphisms and Longevity Syndrome
por: Kolovou, Genovefa, et al.
Publicado: (2010)

Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors
por: Mabuchi, Hiroshi, et al.
Publicado: (2014)

Fluorescent Sterols and Cholesteryl Esters as Probes for Intracellular Cholesterol Transport
por: Solanko, Katarzyna A., et al.
Publicado: (2016)

Structure-based mechanism and inhibition of cholesteryl ester transfer protein
por: Xue, Han, et al.
Publicado: (2023)

Cholesteryl Ester Transfer Protein Gene and Effectiveness of Lipid Lowering of Atorvastatin
por: Kolovou, Genovefa, et al.
Publicado: (2010)

Cholesteryl Esters Accumulate in the Heart in a Porcine Model of Ischemia and Reperfusion
por: Drevinge, Christina, et al.
Publicado: (2013)

The Proteome of Cholesteryl-Ester-Enriched Versus Triacylglycerol-Enriched Lipid Droplets
por: Khor, Victor K., et al.
Publicado: (2014)

Cholesteryl ester transfer protein: ace of spades, queen of hearts, or the joker?
por: Miller, Norman E.
Publicado: (2015)

REVEAL Study: Reveals the Limitations of Cholesteryl Ester Transfer Protein Inhibition
por: Pareek, Anil, et al.
Publicado: (2018)

Cholesterol is Inefficiently Converted to Cholesteryl Esters in the Blood of Cardiovascular Disease Patients
por: Gerl, Mathias J., et al.
Publicado: (2018)

Cholesteryl ester levels are elevated in the caudate and putamen of Huntington’s disease patients
por: Phillips, Gabrielle R., et al.
Publicado: (2020)

Correlation of cholesteryl ester metabolism to pathogenesis, progression and disparities in colorectal Cancer
por: Liu, Zhirong, et al.
Publicado: (2022)

The cholesteryl ester transfer protein (CETP) raises cholesterol levels in the brain
por: Oestereich, Felix, et al.
Publicado: (2022)

Hepatocyte-specific deletion of lysosomal acid lipase leads to cholesteryl ester but not triglyceride or retinyl ester accumulation
por: Pajed, Laura, et al.
Publicado: (2019)

Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho
por: Kanda, Eiichiro, et al.
Publicado: (2016)

Morphological characterization of the cholesteryl ester cycle in cultured mouse macrophage foam cells
Publicado: (1983)

Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases
por: Shinkai, Hisashi
Publicado: (2012)

Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein
por: Duwensee, Kristina, et al.
Publicado: (2011)

The effect of cholesteryl ester transfer protein on pancreatic beta cell dysfunction in mice
por: Guo, Wen, et al.
Publicado: (2016)

Quinoline-3-carboxamide Derivatives as Potential Cholesteryl Ester Transfer Protein Inhibitors
por: Li, Wen-Yan, et al.
Publicado: (2012)

Comparative studies of three cholesteryl ester transfer proteins and their interactions with known inhibitors
por: Wang, Ziyun, et al.
Publicado: (2017)

From Inert Storage to Biological Activity—In Search of Identity for Oxidized Cholesteryl Esters
por: Gonen, Ayelet, et al.
Publicado: (2020)

Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
por: Schmidt, Amand F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8l68mhq79d90254phvomv5ptln